Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 46 of 1,261
  1. US 12286395

    Method of synthesis of an ionizable cationic lipid

    ARCTURUS THERAPEUTICS, INC. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  2. US 12286402

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  3. US 12286630

    Treatment methods for muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  4. US 12286400

    Isofagomine salts, methods of use and formulations

    Takeda Pharmaceutical Company Limited · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  5. US 12286405

    Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  6. US 12285627

    Fabrication and irradiation of a radioactive isotope skin patch

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  7. US 12286657

    Methods and compositions

    United Kingdom Research and Innovation · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  8. US 12285485

    Methods of treating pain

    Semnur Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  9. US 12286479

    Treatment with anti-α4β7 antibody

    Takeda Pharmaceutical Company Limited · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  10. US 12285460

    Pharmaceutical compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  11. US 12285496

    Gene therapy for haploinsufficiency

    The Regents of the University of California · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  12. US 12285397

    Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders

    OVID THERAPEUTICS INC. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  13. US 12286407

    Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases

    The Regents of the University of California · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  14. US 12285404

    Prevention of rosacea inflammation

    The Regents of the University of California · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  15. US 12286406

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  16. US 2025129145

    BI- AND MULTIVALENT ALBUMIN BINDERS

    ABLYNX NV [BE] · Granted Apr 24, 2025 · Expires Apr 19, 2045

    granted
  17. EP 4541380

    STABILE KONZENTRIERTE RADIONUKLID-KOMPLEX-LÖSUNGEN

    ADVANCED ACCELERATOR APPLICATIONS S A [FR] · Granted Apr 23, 2025 · Expires Apr 18, 2045

    granted
  18. US 12280037

    Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

    EVOFEM BIOSCIENCES, INC. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  19. US 12281140

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  20. US 12281105

    Contraceptive compounds and methods

    Regents of the University of Minnesota · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  21. US 12281021

    System and method for making boron oxide nanoparticles

    The Regents of the University of California · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  22. US 12281057

    Carboxamides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  23. US 12281060

    Remodilins for airway remodeling and organ fibrosis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  24. US 12281122

    PI3K inhibitors

    Cogent Biosciences, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.